A California health system and four drugmakers have filed dueling arguments over the pharmaceutical companies’ effort to dismiss a fraud [...] …
Category: Pharma Industry
The Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) are requesting comments on how group [...] …
The leading advocacy group for pharmaceutical manufacturers recently published an advertorial in the Washington Post that highlights a range of [...] …
The leading drugmaker advocacy group issued a data-linked map that aims to highlight the extent of contract pharmacy usage by [...] …
The Virginia state senate last Friday unanimously passed a bill that would prohibit drugmaker 340B contract pharmacy restrictions in the [...] …
A key committee in the Oregon state house could vote tomorrow on a bill that would prohibit drugmaker 340B contract [...] …
One influential Republican senator criticized 340B and another Republican senator expressed support for the program during today’s much-awaited Senate committee [...] …
Maryland lawmakers in the state house and senate have introduced companion bills that would prohibit drugmaker 340B contract pharmacy restrictions [...] …
Several national hospital groups name 340B contract pharmacy protections, among other 340B goals, in their 2024 advocacy priorities. The American [...] …
Recently released draft congressional legislation to reform the 340B program has drawn positive initial reactions from across the range of [...] …